Nilotinib as a second-line treatment for chronic myeloid leukemia
Gan to Kagaku ryoho. Cancer & Chemotherapy, 2011 - europepmc.org
Chronic myeloid leukemia (CML) is a clonal disease of the hematopoietic stem cells that is
characterized by excessive proliferation, but retains of the capacity for differentiation …
characterized by excessive proliferation, but retains of the capacity for differentiation …
Nilotinib as a second-line treatment for chronic myeloid leukemia
T Yamauchi, T Ueda - Gan to kagaku ryoho. Cancer & …, 2011 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a clonal disease of the hematopoietic stem cells that is
characterized by excessive proliferation, but retains of the capacity for differentiation …
characterized by excessive proliferation, but retains of the capacity for differentiation …